JAK1 and neoplasm: For example, parallel comparisons of apoptosis and DNA damage in RA-treated JAK1 overexpressed PC-9 cells incubated with AZD3759 and osimertinib will be conducted, as well as a parallel comparison of their anti-tumor efficacies in vivo.